- Home
- AXSM vs GGAL Comparison
AXSM vs GGAL Comparison
Compare AXSM & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- GGAL
- Stock Information
- Founded
- AXSM 2012
- GGAL 1905
- Country
- AXSM United States
- GGAL Argentina
- Employees
- AXSM N/A
- GGAL N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- GGAL Commercial Banks
- Sector
- AXSM Health Care
- GGAL Finance
- Exchange
- AXSM Nasdaq
- GGAL Nasdaq
- Market Cap
- AXSM 4.0B
- GGAL 4.1B
- IPO Year
- AXSM 2015
- GGAL N/A
- Fundamental
- Price
- AXSM $91.75
- GGAL $43.48
- Analyst Decision
- AXSM Strong Buy
- GGAL Strong Buy
- Analyst Count
- AXSM 14
- GGAL 3
- Target Price
- AXSM $124.57
- GGAL $48.00
- AVG Volume (30 Days)
- AXSM 436.2K
- GGAL 1.2M
- Earning Date
- AXSM 11-04-2024
- GGAL 09-26-2024
- Dividend Yield
- AXSM N/A
- GGAL 5.74%
- EPS Growth
- AXSM N/A
- GGAL 601.06
- EPS
- AXSM N/A
- GGAL 0.66
- Revenue
- AXSM $291,489,000.00
- GGAL $6,469,996,873.00
- Revenue This Year
- AXSM $42.50
- GGAL N/A
- Revenue Next Year
- AXSM $69.28
- GGAL $27.50
- P/E Ratio
- AXSM N/A
- GGAL $8.46
- Revenue Growth
- AXSM 59.73
- GGAL 533.70
- 52 Week Low
- AXSM $55.02
- GGAL $10.57
- 52 Week High
- AXSM $98.40
- GGAL $43.93
- Technical
- Relative Strength Index (RSI)
- AXSM 57.58
- GGAL 74.19
- Support Level
- AXSM $91.52
- GGAL $40.03
- Resistance Level
- AXSM $96.56
- GGAL $42.86
- Average True Range (ATR)
- AXSM 2.97
- GGAL 2.09
- MACD
- AXSM 0.01
- GGAL 0.43
- Stochastic Oscillator
- AXSM 51.16
- GGAL 95.87
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.